Atrial Fibrillation Risk With Cancer Drugs Underestimated Atrial Fibrillation Risk With Cancer Drugs Underestimated

Many cancer therapies increase the risk of atrial fibrillation, but this is underreported in clinical trials, and so oncologists may underestimate the risk of this adverse event.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news